1. Hypolipidemic and antiatherogenic effects of Cynara scolymus in cholesterol-fed rats
- Author
-
Leila Zanatta, Walter Antônio Roman Junior, Greicy M.M. Conterato, Rafael Chitolina, Amanda P. Schönell, Marta Giachini, Ricieri Mocelin, Adrieli Sachett, Fernanda Bevilaqua, Silvana M. Wildner, Marta M.M.F. Duarte, Glaucia Dal Santo, Matheus Marcon, Denise B. Gomes, and Angelo Luis Stapassoli Piato
- Subjects
lcsh:RS1-441 ,030204 cardiovascular system & hematology ,Asteraceae ,lcsh:Pharmacy and materia medica ,Pharmacology, Toxicology and Pharmaceutics(all) ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Animal science ,Antihyperlipidemic ,medicine ,General Pharmacology, Toxicology and Pharmaceutics ,Aqueous extract ,biology ,Chemistry ,Cholesterol ,Cynara scolymus ,Cholic acid ,Artichoke ,biology.organism_classification ,Treatment period ,Enzyme assay ,Biochemistry ,Simvastatin ,030220 oncology & carcinogenesis ,biology.protein ,lipids (amino acids, peptides, and proteins) ,Scolymus ,Antiatherogenic ,medicine.drug - Abstract
Cynara scolymus L., Asteraceae, are traditionally used to treat dyspepsia. This study evaluated the hypolipidemic and antiatherogenic effects of an aqueous extract prepared from the leaves of C. scolymus in rat's model. Hypercholesterolemic rats (1% cholesterol and 0.5% cholic acid for 15 days) were treated (0.5 ml/200 g) with extract of C. scolymus (150, 300, or 600 mg/kg p.o.; n = 6) or simvastatin (4 mg/kg p.o.; n = 6) once per day for 30 days along with hypercaloric diet. A control group (C) was given water (0.5 ml/200 g; n = 6). A high-cholesterol diet was maintained throughout the treatment period. Rats treated with extract of C. scolymus (150, 300, or 600 mg/kg) and simvastatin showed significant decreases in serum levels of total cholesterol (−46.9%, −51.9%, −44%, and −41.9%, respectively) and low-density lipoprotein-cholesterol (LDL-C; −52.1%, −54.8%, −51.9%, and −46.7%, respectively), compared with group C (p
- Published
- 2016